Mereo BioPharma (MREO) Capital Expenditures (2025)
Mereo BioPharma (MREO) posted quarterly Capital Expenditures of $20000.0 for Q1 2025.
Mereo BioPharma (MREO) Capital Expenditures (2025) Analysis & Trends
Mereo BioPharma (MREO) has reported Capital Expenditures for 1 consecutive years, with $20000.0 the latest figure, recorded in Q1 2025.
- Quarterly Capital Expenditures changed N/A year-over-year to $20000.0 in Q1 2025, while the trailing twelve-month figure through Dec 2025 was $20000.0 (changed N/A YoY) and the FY2025 annual result came in at $20000.0, changed N/A from the prior year.
- Capital Expenditures was little changed at $20000.0 in Q1 2025 per MREO's latest filing.
- Over the last five years, Capital Expenditures for MREO reached as high as $20000.0 in Q1 2025 and fell as low as $20000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | Mereo BioPharma | 232.52 Mn | 232.52 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 20,000.00 |
| Mar 31, 2025 | 20,000.00 |